HUP0301863A2 - Treatment of anxiety disorders by selective norepinephrine reuptake inhibitors - Google Patents

Treatment of anxiety disorders by selective norepinephrine reuptake inhibitors

Info

Publication number
HUP0301863A2
HUP0301863A2 HU0301863A HUP0301863A HUP0301863A2 HU P0301863 A2 HUP0301863 A2 HU P0301863A2 HU 0301863 A HU0301863 A HU 0301863A HU P0301863 A HUP0301863 A HU P0301863A HU P0301863 A2 HUP0301863 A2 HU P0301863A2
Authority
HU
Hungary
Prior art keywords
treatment
norepinephrine reuptake
reuptake inhibitors
anxiety disorders
selective norepinephrine
Prior art date
Application number
HU0301863A
Other languages
Hungarian (hu)
Inventor
David Michelson
Holly Read Thomasson
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Priority claimed from PCT/US2001/027801 external-priority patent/WO2002040006A2/en
Publication of HUP0301863A2 publication Critical patent/HUP0301863A2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Selective norepinephrine reuptake inhibitor is used in the manufacture of medicament for the treatment of anxiety disorder. ACTIVITY : Tranquilizer; Nootropic. MECHANISM OF ACTION : Norepinephrine reuptake inhibitor.
HU0301863A 2000-11-15 2001-11-06 Treatment of anxiety disorders by selective norepinephrine reuptake inhibitors HUP0301863A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24901000P 2000-11-15 2000-11-15
US26536200P 2000-11-15 2000-11-15
PCT/US2001/027801 WO2002040006A2 (en) 2000-11-15 2001-11-06 Treatment of anxiety disorders

Publications (1)

Publication Number Publication Date
HUP0301863A2 true HUP0301863A2 (en) 2003-09-29

Family

ID=28456874

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301863A HUP0301863A2 (en) 2000-11-15 2001-11-06 Treatment of anxiety disorders by selective norepinephrine reuptake inhibitors

Country Status (1)

Country Link
HU (1) HUP0301863A2 (en)

Similar Documents

Publication Publication Date Title
MY150740A (en) Low dose methods for treating disorders in which tnf? activity is detrimental
BR0312785A (en) Treatment of Tnf-related disorders (alpha)
MY134110A (en) Combinations of reboxetine and neuroleptic agents
HK1091418A1 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
WO2001062236A3 (en) New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
DE50208008D1 (en) TIOTROPIC SALTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
PT840601E (en) THIP FOR THE TREATMENT OF SLEEP DISORDERS
DK0804236T3 (en) Use of anti-TNF antibodies as drugs to treat diseases involving elevated interleukin-6 serum levels
DE60044152D1 (en) Bupropion metabolite for the treatment of anxiety
DK1694318T3 (en) (S) -2-N-propylamino-5-hydroxytetraline as D3 agonist therapeutic
ATE447403T1 (en) CANNABINOIDS FOR THE TREATMENT OF BREATHING DISORDERS THAT OCCUR DURING SLEEP
CY1106155T1 (en) USE OF 3-BENZOPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF AMPHIBLISTROID DISORDERS
MY136367A (en) Treatment of cognitive failure
BR0115301A (en) Use of a selective norepinephrine reuptake inhibitor
NO20061425L (en) The combination of a serotonin reuptake inhibitor and loxapine
HUP0301863A2 (en) Treatment of anxiety disorders by selective norepinephrine reuptake inhibitors
AU2002347984A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
IT1317073B1 (en) Production of phenylbutyric acid esters for therapeutic use
SE0100873D0 (en) Method of treatment
PT1282414E (en) FELBAMATE-DERIVED COMPOUNDS FOR THE TREATMENT OF NEUROPATIC PAIN
JP2004508006A5 (en)
WO2005020976A3 (en) Treatment of pervasive developmental disorders with norepinephrine reuptake inhibitors
ECSP034599A (en) TREATMENT OF ANXIETY DISORDERS
WO2004103356A3 (en) Treatment of emotional dysregulation
IT1317745B1 (en) Acetylsalicylic acid composition, useful for the primary prevention of thrombosis and other cardiocerebrovascular diseases

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees